The main detail
Viralytics is pleased to announce that MSD has received notice that the Australian
Foreign Investment Review Board (FIRB) has decided that the Commonwealth of
Australia has no objection to MSD acquiring all of the ordinary shares in Viralytics.
MSD has also informed Viralytics that no objections have been raised by US
authorities on the HSR (Hart Scott Rodino) filing required for the Scheme.
VLA Price at posting:
$1.73 Sentiment: Hold Disclosure: Held